Safety and tolerability of Neoral in transplant recipients

被引：0
|
作者：
Feutren, G [1 ]
Wong, R [1 ]
Jin, J [1 ]
Niese, D [1 ]
Mellein, B [1 ]
机构：
[1] SANDOZ PHARMA LTD,CLIN RES,CH-4002 BASEL,SWITZERLAND
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2177 / 2182
页数：6
相关论文
共 50 条
  • [21] Neoral decreases severity of neurotoxicity in liver transplant recipients
    Wijdicks, EFM
    Wiesner, RH
    Dahlke, LJ
    NEUROLOGY, 1999, 52 (06) : A63 - A63
  • [22] Conversion from sandimmune to neoral and induction therapy with neoral in pediatric renal transplant recipients
    Hoyer, PF
    Boekenkamp, A
    Vester, U
    Offner, G
    Brodehl, J
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2259 - 2261
  • [23] Use of cyclosporine MEPC (Neoral) in heart transplant recipients
    Fukushima, N
    Ohtake, S
    Sawa, Y
    Nishimura, M
    Kobayashi, Y
    Shirakura, R
    Nakata, S
    Matsuda, H
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3337 - 3338
  • [24] Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients
    Slizien, Zuzanna
    Muchlado, Marta
    Kubanek, Alicja
    Biedunkiewicz, Bogdan
    Renke, Marcin
    Komorowska, Karolina
    Debska-Slizien, Alicja
    Tylicki, Leszek
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (04) : 878 - 883
  • [25] A randomized, controlled, double-blind study of the safety and tolerability of sandimmun neoral in stable renal transplant patients
    Massari, PU
    Grosso, S
    deBoccardo, G
    Vasquez, MC
    Schiavelli, RO
    Sabbatiello, RR
    Casadei, DH
    Rial, MD
    Jost, LJ
    Turin, MD
    Carreno, CAA
    Maggiora, EC
    Gadea, MM
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 3365 - 3367
  • [26] Assessing safety and efficacy of Neoral®/Everolimus maintenance therapy in cardiac transplant recipients:: 12 month data
    Ross, H.
    Burton, J.
    Pflugfelder, P.
    Cantarovich, M.
    Ignaszewski, A.
    Howlett, J.
    White, M.
    Haddad, H.
    Dorent, R.
    Sips, C.
    Vaillancourt, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S231 - S231
  • [27] Evaluation of the safety and tolerability of Neoral and Sandimmune: A meta-analysis
    Shah, MB
    Martin, JE
    Schroeder, TJ
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1697 - 1700
  • [28] Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients - A report of the Canadian Neoral Renal Study Group
    Cole, E
    Keown, P
    Landsberg, D
    Halloran, P
    Shoker, A
    Rush, D
    Jeffrey, J
    Russell, D
    Stiller, C
    Muirhead, N
    Paul, L
    Zaltzman, J
    Loertscher, R
    Daloze, P
    Dandavino, R
    Boucher, A
    Handa, P
    Lawen, J
    Belitsky, P
    Parfrey, P
    Tan, A
    Hendricks, L
    TRANSPLANTATION, 1998, 65 (04) : 505 - 510
  • [29] The effect of neoral on plasma cholesterol concentration in renal transplant recipients
    Konstadinidou, I
    Boletis, JN
    Chelioti, H
    Avdikou, K
    Theodoropoulou, H
    Gounari, P
    Kostakis, A
    Stathakis, CP
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2393 - 2394
  • [30] Neoral pharmacokinetics in Latino and Caucasian pediatric renal transplant recipients
    J. Lemire
    Edmund V. Capparelli
    Nadine Benador
    Paul Grimm
    Dina Macdonald
    Vivian Reznik
    Pediatric Nephrology, 2001, 16 : 311 - 314
12345